Calpastatin modulates APP processing in the brains of 尾-amyloid depositing but not wild-type mice
详细信息查看全文 | 推荐本文 |
摘要
We report that neuronal overexpression of the endogenous inhibitor of calpains, calpastatin (CAST), in a mouse model of human Alzheimer's disease (AD) 尾-amyloidosis, the APP23 mouse, reduces 尾-amyloid (A尾) pathology and A尾 levels when comparing aged, double transgenic (tg) APP23/CAST with APP23 mice. Concurrent with A尾 plaque deposition, aged APP23/CAST mice show a decrease in the steady-state brain levels of the amyloid precursor protein (APP) and APP C-terminal fragments (CTFs) when compared with APP23 mice. This CAST-dependent decrease in APP metabolite levels was not observed in single tg CAST mice expressing endogenous APP or in younger, A尾 plaque predepositing APP23/CAST mice. We also determined that the CAST-mediated inhibition of calpain activity in the brain is greater in the CAST mice with A尾 pathology than in non-APP tg mice, as demonstrated by a decrease in calpain-mediated cytoskeleton protein cleavage. Moreover, aged APP23/CAST mice have reduced extracellular signal-regulated kinase 1/2 (ERK1/2) activity and tau phosphorylation when compared with APP23 mice. In summary, in vivo calpain inhibition mediated by CAST transgene expression reduces A尾 pathology in APP23 mice, with our findings further suggesting that APP metabolism is modified by CAST overexpression as the mice develop A尾 pathology. Our results indicate that the calpain system in neurons is more responsive to CAST inhibition under conditions of A尾 pathology, suggesting that in the disease state neurons may be more sensitive to the therapeutic use of calpain inhibitors.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700